Pediatric Powered Wheelchair Standing Devices: An Exploratory Study
study id #: NCT05117827
condition: Cerebral Palsy, Spinal Muscular Atrophy, Spinal Cord Injuries, Spina Bifida, Development Delay, Genetic Disease
For children who use a power wheelchair, a powered wheelchair standing device (PWSD) may be considered for daily use. A PWSD allows a child to electronically move between sitting and standing and can be driven in either position. Existing published PWSD research in pediatrics is limited to boys with Duchenne muscular dystrophy (DMD).(1, 2) While these studies provide some insights into PWSD use in boys with DMD, they do not reflect PWSD use in children with other conditions. The purpose of this exploratory study is to determine the feasibility of a research protocol exploring use of a PWSD in children who have neurodevelopmental conditions other than DMD.
intervention: Power Wheelchair Standing Device
last updated: February 04, 2022
start date: November 15, 2021
estimated completion: October 31, 2023
last updated: November 11, 2021
phase of development: Not Applicable
size / enrollment: 5
- Participation in children
Does using a PWSD increase participation in children who have neurodevelopmental conditions other than DMD?
- 2 years
- Parental/caregiver perceptions
- Children's perceptions
• Eligible Sexes: all
Is 5-17 years of age. NOTE: Participants must be under 18 for the duration of the study.
Diagnosed with a neurodevelopmental condition resulting in an inability to functionally ambulate.
Can safely assume and maintain a supported standing position
Has sufficient upper extremity and function to safely use a PWSD
Can communicate pain or discomfort through verbalization, vocalization, use of augmented communication, etc.
Can safely use the PWSD in areas of their home
Has at least one parent/caregiver who is able to converse in English and actively participate in a device-use education provided in English
The PerMobil PWSD can be set up to meet the child's specific needs
Medical Clearance to trial the PWSD
Participants must reside in Michigan
exclusion criteria: Criteria:
Has a diagnosis of Duchenne muscular dystrophy.
Any reason that it would not be safe for the child to use a PWSD
SMA Type 2 – Looking After Your Child Who Has Had a Recent DiagnosisOne of the first questions many families...
Infantile Hypotonia: A Case of Spinal Muscular Atrophy With Respiratory Distress Type 1 Presenting As Infant Botulis...Spinal muscular atrophy with respiratory...
H-NMR-Based Metabolic Profiling Identifies Non-Invasive Diagnostic and Predictive Urinary Fingerprints in 5q Spinal ...5q spinal muscular atrophy (SMA) is a di...
Thomas Crawford, MDDr. Tom Crawford has been a member of th...
Improvement in Fine Manual Dexterity in Children With Spinal Muscular Atrophy Type 2 After Nusinersen Injection: A C...Although nusinersen has been demonstrate...
SMA Angels Charity – Facebook100% Volunteer, 501 (c)(3) non-profit de...
Spinal Muscular Atrophy 2019: SMA Pathophysiology, Diagnosis and Clinical Presentationshttps://www.youtube.com/watch?v=cUuWue8M...